SWOG Cancer Research Network
@SWOG
Followers
14K
Following
16K
Media
2K
Statuses
15K
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.
United States
Joined January 2012
Are you getting treatment for muscle invasive bladder cancer? Ask your doctor about S2427 (BRIGHT). It’s a #ClinicalTrial testing whether an immunotherapy drug plus radiation therapy can help patients keep their bladder. https://t.co/WWqP6qxd2M. 1-800-4-CANCER. #MIBC
0
0
0
What’s the best consolidation tx for patients newly diagnosed with #ALamyloidosis: #StemCellTransplant w melphalan? Or daratumumab + VCD? Trial S2213 also compares minimal residual disease negativity rates. TM Co-PI: Brian Walker, PhD @IUMedSchool
https://t.co/j7v1cZOwp7
0
2
2
Analysis from the DART trial across multiple #rarecancer types: Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multi-Center Basket Trial Analysis (NCI/SWOG S1609)
aacrjournals.org
Abstract. Purpose: To evaluate the efficacy and safety of dual immune checkpoint inhibitors (ICI) in patients with brain metastases (BM) from rare cancers. Patients and Methods: Patients with and...
0
2
4
Honored to publish our study: "Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women" in Jama Oncology! https://t.co/Rfx7v7DHAD
@SWOG @KalinskyKevin @lynnhenrymd @ExactSciences
jamanetwork.com
This secondary analysis of the RxPONDER randomized clinical trial assesses patient-reported cognitive impairment by menopausal status among women with breast cancer treated with chemoendocrine...
4
15
43
Awesome 👏🏾 @barbarasegarra 👏🏾 Honored to be included in @barbarasegarra’s plenary session @SABCSSanAntonio and proud to work alongside you! @SWOG @OncoAlert @oncodaily #breastcancer #bcsm #advocates #clinicaltrials #research #oncoalert #SABCS25
0
5
8
Creatine HMB enhances cognitive function and supports muscle health*
2
4
10
Are you starting treatment for #ALAmyloidosis? Ask your doctor about #clinicaltrial S2213. It compares using a drug combination called Dara-VCD vs. stem cell transplant. Learn more at https://t.co/0h5ZRC6aze. Or call 1-800-4-CANCER. #raredisease
0
1
3
The S2409 PRISM trial biomarker-tests patients with extensive stage small cell #LungCancer during induction treatment and assigns them to 1 of 3 maintenance therapy cohorts based on #SCLC subtype and SLFN11 status. #LCSM Co-PI: So Yeon Kim, MD @YaleCancer
https://t.co/xLcUDLFeRa
0
1
4
S2427 BRIGHT tests IO + RT as bladder-preserving treatment for patients with #MIBC who respond to NAT. Focal, non-diffuse carcinoma in situ (CIS) is allowed. Systematic biopsies needed at post-NAT TURBT. Co-PI: Daniel A. Hamstra, MD, PhD @BCMCancerCenter
https://t.co/h6AYneI4Qt
0
0
3
What does it mean to be a modern day Maccabee? @chiefrabbi Mirvis joins the Boundless Insights podcast to explain 🎧 Find us where you find podcasts!
3
15
39
The @SWOG has joined @WIN_Consortium allying two organizations with deeply aligned missions to accelerate progress against cancer and advance precision oncology and biomarker-driven research. @weldeiry @Dr_R_Kurzrock @SWOGChair
0
5
8
AL #amyloidosis trial S2213 compares autologous transplant to Dara-VCD consolidation. Also compares post-consolidation #PatientReportedOutcomes for physical function and other #HRQoL measures. QoL/PRO Co-PI: @Terri_ParkerMD @YaleCancer
https://t.co/j7v1cZOwp7
0
4
5
S2427 (BRIGHT) is a study for people who were treated for muscle invasive #BladderCancer — and the cancer shrunk or can’t be found after treatment. The study asks if a drug plus radiation can help prevent bladder removal. Visit https://t.co/WWqP6qxd2M. Or call 1-800-4-CANCER.
0
2
3
S2409 (the PRISM trial) is a study for people with extensive stage small cell lung cancer (ES-SCLC). The goal is to match different #SCLC subtypes with the best treatment. Visit https://t.co/JK0Y59hyUJ. Or call 1-800-4-CANCER. #LCSM
0
6
7
California’s New Target: Beverly Hills. Within 20 minutes, you can drive from successful, capitalist Beverly Hills to decaying, socialist Santa Monica—two completely different worlds shaped by completely different values.
8
34
100
Our @SWOGChair blog: SWOG at SABCS: A Record of Success The San Antonio Breast Cancer Symposium has been a prime venue for publishing important SWOG research results in breast cancer treatment, symptom management, and prevention. #SABCS25
https://t.co/cVjCaGnT8B
1
3
11
On my way to SABCS. Excited & a little scared, as I carry the huge responsibility of representing the hundreds of advocates who have been working for decades to bring patients’ needs & experiences into research.Plenarysession Thursday 8:30. Thank you @SWOG for all I have learned!
2
1
10
Fred Hutch's @MinFang17 presenting work at #ASH25 showing chromosome genomic array testing (CGAT) improves diagnostic yield in patients with #AML and #MDS and has the potential for better risk stratification - a @theNCI myelomatch and @SWOG report. https://t.co/EjMQIOSQXz
0
2
7
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation [Jan 10, 2019] @DrJoeUnger et al. @JAMAOnc
https://t.co/36kRNinM7n
#ClinicalTrials @SWOG #SWOGonc
jamanetwork.com
This national survey study of patients with cancer evaluates the association between patient comorbid conditions and cancer clinical trial participation.
0
1
4
The @theNCI #MyeloMATCH precision medicine trial for #AML or #MDS has some initial results that are being presented in an oral presentation and 5 posters at the #ASH25 meeting this weekend! Find out more here > https://t.co/3F00YotqjI
@SWOG
@eaonc
@ALLIANCE_org
#NCORP
0
3
5
“A lot of my movies are about, in some ways, ‘How do I define myself in the world, and am I that person?’” “Jay Kelly” co-writer and director Noah Baumbach discusses the concept of identity in his latest film with IndieWire, and shares more behind-the-scenes of the film with
2
21
163
Enrolling: @SWOG S2213 in newly diagnosed #ALamyloidosis. Daratumumab + VCD induction, then randomization to autologous stem cell transplant or Dara-VCD consolidation. Patients on both arms get dara maintenance. Co-PI: @SurbhiSidanaMD @StanfordMed
https://t.co/j7v1cZOwp7
0
3
3
#Clinicaltrial S2213 asks if a drug combination (called Dara-VCD) or stem cell transplant is better for people with AL #amyloidosis. The trial is for people who haven’t started treatment yet. Learn more at https://t.co/0h5ZRC6aze. Or call 1-800-4-CANCER.
0
1
2
Isatuximab for relapsed and/or refractory AL amyloidosis. N=43, hematologic response: 77%, renal response: 50%, cardiac response: 57% @Myeloma_Doc #amyloidosis @SWOG
https://t.co/gsF1fUQGkE
0
3
10